Rote William E.
Chief Research Officer at TVTX
- Sold, on record
- $18.4M
- Dollars the filings state
- Form 4 sales
- 38
- Latest Sep 16, 2026
- Form 144 notices
- 6
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- TVTXTravere Therapeutics, Inc.Chief Research Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale TVTXUnusualFeb 3, 2025 2025
Sold 8,951 shares at $19.78 ($177k)
Rote William E., SENIOR VICE PRESIDENT, R&D
10b5-1 planSold 8.6% of holdings ($2.1M position)95,719 shares left4x usual sizeFiling
- 2 Form 4 sale TVTXRoutineFeb 12, 2025 +9 days
Sold 5,200 shares at $23.53 ($122k)
Rote William E., SENIOR VICE PRESIDENT, R&D
10b5-1 planSold 5% of holdings ($2.4M position)98,519 shares left2.1x usual sizeFiling
- 3 Form 4 sale TVTXRoutineMay 5, 2025 +82 days
Sold 3,198 shares at $21.05 ($67k)
Rote William E., Chief Research Officer
10b5-1 planSold 3.1% of holdings ($2.2M position)100,241 shares left0.9x usual sizeFiling
- 4 Form 4 sale TVTXUnusualDec 24, 2025 +233 days
Sold 60,000 shares at $40.10 ($2.4M)
Rote William E., Chief Research Officer
10b5-1 planSold 37.2% of holdings ($6.5M position)101,443 shares left13.7x usual sizeFiling
- 5 Form 4 sale TVTXRoutineFeb 3, 2026 +41 days
Sold 12,446 shares at $32.87 ($409k)
Rote William E., Chief Research Officer
10b5-1 planSold 10.2% of holdings ($4M position)109,087 shares left2.6x usual sizeFiling
- 6 Form 4 sale TVTXRoutineApr 22, 2026 +78 days
Sold 9,100 shares at $39.09 ($356k)
Rote William E., Chief Research Officer
10b5-1 planSold 7.4% of holdings ($4.8M position)113,987 shares left1.8x usual sizeFiling
- 7 Form 4 sale TVTXRoutineMay 6, 2026 +14 days
Sold 2,763 shares at $43.95 ($121k)
Rote William E., Chief Research Officer
10b5-1 planSold 2.3% of holdings ($5.2M position)115,474 shares left0.4x usual sizeFiling
- 8 Form 4 sale TVTXUnusualSep 16, 2026 +133 days
Sold 209,048 shares at $62.83 ($13.1M)
Rote William E., Chief Research Officer
10b5-1 planSold 68% of holdings ($19.3M position)98,197 shares left29.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (44)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 16, 2026 | Sep 17, 2026 | TVTX | Chief Research Officer | Form 4 sale | 209,048 | $13.1M | 68.0% | Unusual | SEC |
| May 6, 2026 | May 6, 2026 | TVTX | Chief Research Officer | Form 4 sale | 2,763 | $121k | 2.3% | Routine | SEC |
| Apr 22, 2026 | Apr 23, 2026 | TVTX | Chief Research Officer | Form 4 sale | 9,100 | $356k | 7.4% | Routine | SEC |
| Feb 3, 2026 | Feb 3, 2026 | TVTX | Chief Research Officer | Form 4 sale | 12,446 | $409k | 10.2% | Routine | SEC |
| Dec 24, 2025 | Dec 29, 2025 | TVTX | Chief Research Officer | Form 4 sale | 60,000 | $2.4M | 37.2% | Unusual | SEC |
| May 5, 2025 | May 5, 2025 | TVTX | Chief Research Officer | Form 4 sale | 3,198 | $67k | 3.1% | Routine | SEC |
| Feb 12, 2025 | Feb 12, 2025 | TVTX | SENIOR VICE PRESIDENT, R&D | Form 4 sale | 5,200 | $122k | 5.0% | Routine | SEC |
| Feb 3, 2025 | Feb 4, 2025 | TVTX | SENIOR VICE PRESIDENT, R&D | Form 4 sale | 8,951 | $177k | 8.6% | Unusual | SEC |
| Jan 22, 2025 | Jan 23, 2025 | TVTX | SENIOR VICE PRESIDENT, R&D | Form 4 sale | 2,437 | $47k | 2.8% | Routine | SEC |
| Sep 9, 2024 | Sep 9, 2024 | TVTX | SENIOR VICE PRESIDENT, R&D | Form 4 sale | 4,387 | $51k | 4.9% | Routine | SEC |
| Sep 9, 2024 | Sep 9, 2024 | TVTX | Officer | Form 144 notice | 4,387 | $51k | Notice | SEC | |
| Feb 1, 2024 | Feb 2, 2024 | TVTX | SENIOR VICE PRESIDENT, R&D | Form 4 sale | 4,764 | $41k | 5.6% | No plan | SEC |
| Feb 1, 2024 | Feb 1, 2024 | TVTX | Officer | Form 144 notice | 2,174 | $19k | Notice | SEC | |
| Feb 1, 2024 | Feb 1, 2024 | TVTX | Officer | Form 144 notice | 2,590 | $23k | Notice | SEC | |
| Jan 23, 2024 | Jan 25, 2024 | TVTX | SENIOR VICE PRESIDENT, R&D | Form 4 sale | 2,062 | $18k | 3.3% | No plan | SEC |
| Jan 23, 2024 | Jan 23, 2024 | TVTX | Officer | Form 144 notice | 2,062 | $18k | Notice | SEC | |
| Sep 5, 2023 | Sep 5, 2023 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,815 | $27k | 2.9% | No plan | SEC |
| Sep 5, 2023 | Sep 5, 2023 | TVTX | Officer | Form 144 notice | 1,815 | $27k | Notice | SEC | |
| May 10, 2023 | May 12, 2023 | TVTX | Senior Vice President, R&D | Form 4 sale | 825 | $14k | 1.4% | Routine | SEC |
| May 10, 2023 | May 10, 2023 | TVTX | Officer | Form 144 notice | 825 | $14k | Notice | SEC | |
| Feb 1, 2023 | Feb 2, 2023 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,590 | $58k | 4.1% | Plan not stated | SEC |
| Jan 24, 2023 | Jan 26, 2023 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,062 | $44k | 4.6% | Plan not stated | SEC |
| May 11, 2022 | May 12, 2022 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,563 | $34k | 3.5% | Plan not stated | SEC |
| Jan 31, 2022 | Feb 2, 2022 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,125 | $31k | 2.4% | Plan not stated | SEC |
| Jan 24, 2022 | Jan 26, 2022 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,875 | $47k | 4.9% | Plan not stated | SEC |
| Jan 11, 2022 | Jan 12, 2022 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,500 | $69k | 6.1% | Plan not stated | SEC |
| Aug 17, 2021 | Aug 17, 2021 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,407 | $24k | 3.8% | Plan not stated | SEC |
| May 12, 2021 | May 13, 2021 | TVTX | Senior Vice President, R&D | Form 4 sale | 3,125 | $60k | 9.0% | Plan not stated | SEC |
| Feb 18, 2021 | Feb 18, 2021 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,500 | $70k | 6.7% | Plan not stated | SEC |
| Feb 8, 2021 | Feb 9, 2021 | TVTX | Senior Vice President, R&D | Form 4 sale | 4,500 | $142k | 10.8% | Plan not stated | SEC |
| Feb 3, 2021 | Feb 3, 2021 | TVTX | Senior Vice President, R&D | Form 4 sale | 3,625 | $105k | 8.9% | Plan not stated | SEC |
| Feb 2, 2021 | Feb 2, 2021 | TVTX | Senior Vice President, R&D | Form 4 sale | 3,625 | $111k | 7.7% | Plan not stated | SEC |
| Nov 16, 2020 | Nov 17, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,500 | $60k | 9.4% | Plan not stated | SEC |
| Nov 13, 2020 | Nov 13, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,500 | $59k | 8.6% | Plan not stated | SEC |
| Sep 23, 2020 | Sep 23, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,500 | $28k | 5.9% | Plan not stated | SEC |
| Sep 22, 2020 | Sep 22, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,500 | $28k | 5.5% | Plan not stated | SEC |
| May 12, 2020 | May 13, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,152 | $35k | 8.4% | Plan not stated | SEC |
| Mar 10, 2020 | Mar 12, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 3,250 | $48k | 11.2% | Plan not stated | SEC |
| Feb 18, 2020 | Feb 19, 2020 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,500 | $42k | 8.9% | Plan not stated | SEC |
| May 15, 2019 | May 16, 2019 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,625 | $29k | 8.2% | Plan not stated | SEC |
| Feb 19, 2019 | Feb 20, 2019 | TVTX | Senior Vice President, R&D | Form 4 sale | 2,500 | $54k | 15.3% | Plan not stated | SEC |
| Feb 12, 2019 | Feb 13, 2019 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,985 | $43k | 11.0% | Plan not stated | SEC |
| Nov 15, 2018 | Nov 16, 2018 | TVTX | Senior Vice President, R&D | Form 4 sale | 5,000 | $120k | 21.7% | Plan not stated | SEC |
| Feb 14, 2018 | Feb 16, 2018 | TVTX | Senior Vice President, R&D | Form 4 sale | 1,034 | $22k | 8.5% | Plan not stated | SEC |